Skip to content

Clinical trials

Hepatitis C trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: New Zealand Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20093
20101
201110
20126
20136
20148
201511
20166
20174

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated4
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences27
Bristol-Myers Squibb5
AbbVie4
Janssen R&D Ireland3
Kirby Institute3
Tibotec Pharmaceuticals, Ireland2
Vertex Pharmaceuticals Incorporated2
AbbVie (prior sponsor, Abbott)1
Antipodean Pharmaceuticals, Inc.1
Arrow Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C59
Hepatitis C, Chronic9
Bronchiolitis Obliterans Syndrome7
Fibrosis3
Hepatitis2
Carcinoma, Hepatocellular1
Hypertension, Portal1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.